-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Orthopoxvirus
- Others
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Virus Protease
- Antiviral intermediates
SARS-CoV-2-Mpro-IN-1
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/2758359-91-8.gif)
| Category | SARS-CoV |
| CAS | 2758359-91-8 |
| Description | SARS-CoV-2 Mpro-IN-1 (compound 16b-3) is a potent, selective and irreversible inhibitor of SARS-CoV-2 main protease(Mpro), with an IC50 of 116 nM. |
Product Information
| Synonyms | SARS-CoV-2 Mpro-IN-1|HY-144464|CS-0380464 |
| Molecular Weight | 302.32 |
| Molecular Formula | C15H11FN2O2S |
| Canonical SMILES | C1=CC=C(C=C1)NC(=O)CN2C(=O)C3=C(C=CC=C3S2)F |
| Purity | ≥98% (HPLC) |
| Solubility | In vitro: 10 mM in DMSO |
| Appearance | Solid powder |
| Storage | Store at -20°C |
| Complexity | 415 |
| Exact Mass | 302.05252693 |
| Target | SARS-CoV |
| XLogP3-AA | 2.5 |
